Status:
COMPLETED
Telavancin Observational Use Registry (TOUR)
Lead Sponsor:
Cumberland Pharmaceuticals
Conditions:
Hospital Acquired Bacterial Pneumonia
Complicated Skin and Skin Structure Infections
Eligibility:
All Genders
Brief Summary
The telavancin observational use registry (TOUR) will collect data to support study of the efficacy, safety, and pattern of use of telavancin in hospital-based inpatients and in outpatients being trea...
Detailed Description
This is a retrospective medical chart review, multicenter, observational study to examine telavancin efficacy and safety in a real-word setting and to characterize the pattern of use of telavancin in ...
Eligibility Criteria
Inclusion
- received at least 1 dose of telavancin since January 1, 2015
Exclusion
- Participation in an interventional research study or clinical trial involving telavancin after January 01, 2015
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
1063 Patients enrolled
Trial Details
Trial ID
NCT02288234
Start Date
November 1 2014
End Date
October 1 2017
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Newland Medical Associates
Southfield, Michigan, United States, 48075